International Stem Cell Corp. (OTCMKTS:ISCO) Stock Short Interest Drops 94.1%

International Stem Cell Corp. (OTCMKTS:ISCO) was the recipient of a significant decline in short interest during the month of September. As of September 15th, there was short interest totaling 48 shares, a decline of 94.1% from the August 31st total of 808 shares. Approximately 0.0% of the shares of the stock are sold short. Based on an average daily trading volume, of 124,095 shares, the days-to-cover ratio is currently 0.0 days.

International Stem Cell Stock Up 8.7%

Shares of OTCMKTS:ISCO traded up $0.03 during trading on Thursday, hitting $0.35. 3,100 shares of the company were exchanged, compared to its average volume of 56,727. International Stem Cell has a 1-year low of $0.12 and a 1-year high of $0.54. The company has a market capitalization of $2.76 million and a P/E ratio of -4.32. The business’s 50 day moving average is $0.35 and its 200-day moving average is $0.23.

International Stem Cell (OTCMKTS:ISCO) last released its quarterly earnings data on Thursday, August 13th. The biotechnology company reported ($0.01) earnings per share for the quarter. The company had revenue of $2.67 million during the quarter.

International Stem Cell Company Profile

International Stem Cell Corporation is a biotechnology company focused on developing human stem cell-based products and therapies. Its research has centered on proprietary parthenogenetic human stem cells, which are derived from unfertilized human oocytes and are intended to provide a potentially useful source of cells for regenerative medicine.

The company has pursued applications in tissue engineering and cell therapy, including programs involving corneal tissue and other specialized cell types.